Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate
31 mars 2022 09h00 HE
|
AGC Biologics
Seattle, March 31, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material
08 févr. 2022 19h00 HE
|
AGC Biologics
Heidelberg, Germany, Feb. 08, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded...
AGC Biologics Names Regina Choi-Rivera New General Manager of Boulder, Colorado Mammalian Production Facility
18 janv. 2022 09h05 HE
|
AGC Biologics
Boulder, Colo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Regina Choi-Rivera as...
AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry
20 déc. 2021 08h05 HE
|
AGC Biologics
Milan, Dec. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has won the 2021...
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project
13 déc. 2021 20h05 HE
|
AGC Biologics
Seattle, Dec. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with I-MAB...
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab
01 déc. 2021 09h03 HE
|
AGC Biologics
Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4...
AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer
01 nov. 2021 09h03 HE
|
AGC Biologics
Seattle, Nov. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Jean-Baptiste Agnus has been...
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility
13 sept. 2021 19h57 HE
|
AGC Biologics
Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans...
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
20 août 2021 13h39 HE
|
AGC Biologics
COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new...
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
09 août 2021 13h00 HE
|
AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...